Rubella and Congenital Rubella Syndrome in the Philippines: A Systematic Review

Anna Lena Lopez1, Peter Francis N Raguindin1, Maria Asuncion Silvestre2

  • 1University of the Philippines Manila, National Institutes of Health, Manila, Philippines.

Insights

Rubella-containing vaccines (RCV) were recently introduced in the Philippines. This study assessed rubella and congenital rubella syndrome (CRS) burden, finding susceptible women and CRS-related disabilities, highlighting the need for surveillance.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Vaccinology

Background:

  • Rubella-containing vaccines (RCV) recently introduced in the Philippines for regional elimination efforts.
  • Limited data exists on the true burden of rubella and congenital rubella syndrome (CRS) in the Philippines.
  • Baseline data is crucial before widespread routine vaccine introduction.

Purpose of the Study:

  • To establish baseline information on rubella and CRS prevalence in the Philippines.
  • To assess rubella susceptibility among women of childbearing age.
  • To inform public health strategies for rubella and CRS prevention.

Main Methods:

  • Systematic literature review of 15 local studies on rubella and CRS.
  • Cross-sectional study of 383 pregnant women at Philippine General Hospital in 2002.
  • Serological testing for rubella IgG antibodies to determine susceptibility.

Main Results:

  • Review of 15 studies indicated high rubella susceptibility in rural women.
  • Common CRS manifestations included congenital heart defects, cataracts, and hearing impairments.
  • 15.4% of pregnant women studied were seronegative for rubella IgG, indicating susceptibility.

Conclusions:

  • Surveillance for rubella has only recently been established in the Philippines.
  • Substantial burden of CRS-related disabilities and a significant proportion of susceptible women identified.
  • Prioritizing CRS surveillance and enhancing rubella case detection is recommended.